We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Mawi DNA Technologies, a provider of biosample collection technologies, has secured CE mark approval for its iSWAB non-invasive collection devices. The iSWAB non-invasive collection devices were also approved
Biobot Surgical has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its new robotic-assisted transperineal needle-guidance system for prostate biopsy and cancer ablations. The company
Commercial stage medical device firm LumiThera has wrapped up the acquisition of modern visual electrophysiology medical devices provider Diopsys for an undisclosed sum. Diopsys’s visual electrophysiology medical devices
French medtech company Gleamer has secured approval from the US Food and Drug Administration (FDA) for its BoneView artificial intelligence (AI) software. The approval enables US healthcare specialists
Swift Medical, the global leader in digital wound care technology, unveiled the Swift Ray 1, a groundbreaking hardware device that wirelessly attaches to a smartphone camera and captures
FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER®, a fully Implantable Cardiac Output Management System designed to address the unmet need of patients
ExThera Medical has announced the recruitment of the first patient in the blood purification for the treatment of pathogen associated shock (PURIFY-RCT) trial. Sponsored by the Department of
Health-technology company Intrivo has launched its rapid Covid-19 test called On/Go One for the detection of all major known variants, including Omicron. Recently, the company has received emergency
Retia Medical today announced that it received a Declaration of Compatibility from Philips for its Argos Cardiac Output Monitor to interface with Philips IntelliBridge system on the IntelliVue
Kaléo, a privately held U.S. pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved its Naloxone Auto-injector 10 mg (NALOXONE HYDROCHLORIDE injection) indicated